Automotive Composites Market Set to Surpass US$11.44 billion by 2024, With Innovation and Sustainability Driving Robust Growth

DUBLIN, March 19, 2024 /PRNewswire/ — The “Automotive Composites Market Report 2024-2034” report has been added to ResearchAndMarkets.com’s offering. World revenue for the Automotive Composites Market is forecast to surpass US$11.44 billion in 2024, with strong revenue growth through to 2034.  Rising Demand for Fuel-Efficient and Light-Weight Vehicles Driving Market Growth The market growth of automotive composites… Continue reading Automotive Composites Market Set to Surpass US$11.44 billion by 2024, With Innovation and Sustainability Driving Robust Growth

NeuroDerm: результаты исследования терапии ND0612 при Паркинсоне (BouNDless) положительные

– NeuroDerm объявляет о публикации положительных результатов исследования фазы 3 BouNDless, в ходе которого оценивалось действие терапии ND0612 на пациентов с болезнью Паркинсона с двигательными флуктуациями Опубликованные в The Lancet Neurology данные показали благоприятную эффективность ND0612 по сравнению с пероральным приемом таблеток препарата леводопа/карбидопа с немедленным высвобождением РЕХОВОТ, Израиль, 19 марта 2024 г. /PRNewswire/ —… Continue reading NeuroDerm: результаты исследования терапии ND0612 при Паркинсоне (BouNDless) положительные

NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. fázy 3 štúdie BouNDless, ktorá vyhodnocuje ND0612 u pacientov s Parkinsonovou chorobou s motorickými výkyvmi

Údaje publikované v The Lancet Neurology preukázali priaznivú účinnosť ND0612 v porovnaní s perorálnou levodopou/karbidopou s okamžitým uvoľňovaním REHOVOT, Izrael, 19. marca 2024 /PRNewswire/ — NeuroDerm Ltd., dcérska spoločnosť v úplnom vlastníctve Mitsubishi Tanabe Pharma Corporation (MTPC), dnes oznámila zverejnenie výsledkov v časopise The Lancet Neurology z kľúčovej 3. fázy štúdie BouNDless (NCT04006210). Výsledky štúdie, v ktorej sa… Continue reading NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. fázy 3 štúdie BouNDless, ktorá vyhodnocuje ND0612 u pacientov s Parkinsonovou chorobou s motorickými výkyvmi

U.S. startup Fisker to pause EV production after missing interest payment

(Reuters) — Fisker said on Monday it would pause production of its electric vehicles for six weeks and raise up to $150 million in funding by selling convertible notes after missing an interest payment, as the startup tries to navigate a cash crunch. The company added that none of its Ocean SUVs were produced in… Continue reading U.S. startup Fisker to pause EV production after missing interest payment

U.S. startup Fisker to pause EV production after missing interest payment

(Reuters) — Fisker said on Monday it would pause production of its electric vehicles for six weeks and raise up to $150 million in funding by selling convertible notes after missing an interest payment, as the startup tries to navigate a cash crunch. The company added that none of its Ocean SUVs were produced in… Continue reading U.S. startup Fisker to pause EV production after missing interest payment

EV Roundup: WKHS’ Quarterly Results, NIO-CATL Alliance Draw Attention

The commercial electric vehicle (EV) developer Workhorse Group Inc. WKHS reported mixed fourth-quarter 2023 results and is implementing a reduction in force, impacting 20% of its total workforce, excluding direct labor positions. The EV behemoth Tesla TSLA plans to manufacture its electric semi-truck at Gigafactory Berlin. It also decided to raise the prices of Model Y… Continue reading EV Roundup: WKHS’ Quarterly Results, NIO-CATL Alliance Draw Attention

Společnost NeuroDerm oznámila zveřejnění pozitivních výsledků 3. fáze studie BouNDless, která hodnotí výsledky použití přípravku ND0612 u pacientů s Parkinsonovou chorobou s motorickými fluktuacemi

Údaje publikované v časopise The Lancet Neurology prokázaly příznivé účinky přípravku ND0612 ve srovnání s perorálním podáním levodopy/karbidopy s okamžitým uvolňováním  REHOVOT, Izrael, 19. března 2024 /PRNewswire/ — Společnost NeuroDerm Ltd., dceřiná společnost plně vlastněná společností Mitsubishi Tanabe Pharma Corporation (MTPC), dnes oznámila, že časopis The Lancet Neurology zveřejnil výsledky její klíčové studie 3. fáze BouNDless (NCT04006210). Výsledky… Continue reading Společnost NeuroDerm oznámila zveřejnění pozitivních výsledků 3. fáze studie BouNDless, která hodnotí výsledky použití přípravku ND0612 u pacientů s Parkinsonovou chorobou s motorickými fluktuacemi

Fisker Suspends Its EV Production

Following recent reports that Fisker has been preparing for a possible bankruptcy filing, today the embattled automaker announced that it is suspending all manufacture of its electric vehicles. “Fisker will pause production for six weeks starting the week of March 18, 2024, to align inventory levels and progress strategic and financing initiatives,” the company said… Continue reading Fisker Suspends Its EV Production

Fisker (FSR) stock falls after failing to make an interest payment, pauses EV production

EV startup Fisker (FSR) is pausing EV production for six weeks as its financial struggles worsen. Fisker looks to get its finances in order after failing to make an interest payment. The EV maker did get a commitment for up to $150 million in financing, but will it be enough? Fisker is halting production as… Continue reading Fisker (FSR) stock falls after failing to make an interest payment, pauses EV production

UAW says VW workers at Tennessee plant file for union election

A Volkswagen EV ID.4 crossover at the Volkswagen of America plant in Chattanooga, Tennessee, on June 8, 2022. Michael Wayland | CNBC DETROIT — Volkswagen workers at a plant in Tennessee have filed a petition with the National Labor Relations Board for a vote to join the United Auto Workers, the union announced Monday. The… Continue reading UAW says VW workers at Tennessee plant file for union election